Liminatus Pharma Stock Price, News & Analysis
LIMN
NASDAQ
Company Description
Welcome to the overview page for Liminatus Pharma (LIMN), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$113,287
Net Income (TTM)
$0.00
$8,975,859
Operating Cash Flow
0.17
$1,118,211
—
Revenue (TTM)
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Liminatus Pharma (LIMN)?
The current stock price of Liminatus Pharma (LIMN) is $1.6 as of October 8, 2025.
What is the market cap of Liminatus Pharma (LIMN)?
The market cap of Liminatus Pharma (LIMN) is approximately 42.8M. Learn more about what market capitalization means .
What is the net income of Liminatus Pharma (LIMN)?
The trailing twelve months (TTM) net income of Liminatus Pharma (LIMN) is $113,287.
What is the earnings per share (EPS) of Liminatus Pharma (LIMN)?
The diluted earnings per share (EPS) of Liminatus Pharma (LIMN) is $0.00 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Liminatus Pharma (LIMN)?
The operating cash flow of Liminatus Pharma (LIMN) is $8,975,859. Learn about cash flow.
What is the current ratio of Liminatus Pharma (LIMN)?
The current ratio of Liminatus Pharma (LIMN) is 0.17, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Liminatus Pharma (LIMN)?
The operating income of Liminatus Pharma (LIMN) is $1,118,211. Learn about operating income.